Hysingla ER Abuse and Addiction – Latest News
The FDA Approves Abuse-Deterrent Hydrocodone Pill The FDA has given the go-ahead to Hysingla ER (hydrocodone bitartrate, Purdue Pharma), an extended-release opioid analgesic to manage pain severe enough to require long-term, daily, around-the-clock opioid treatment and for which alternative treatment options are inadequate around-the-clock, long-term. Hysingla ER has qualities that are expected to reduce, but…